OVARIAN CANCER and US: stage 1 ovarian cancer

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label stage 1 ovarian cancer. Show all posts
Showing posts with label stage 1 ovarian cancer. Show all posts

Saturday, April 14, 2012

abstract: Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety - oncologic safety



Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety:

Abstract

The aim of this study was to compare laparoscopic and laparotomic surgical staging in patients with stage I epithelial ovarian cancer in terms of feasibility and safety. A retrospective chart review was undertaken of all patients with apparent stage I epithelial ovarian cancer who underwent laparoscopic (laparoscopy group) or laparotomic (laparotomy group) surgical staging at the Center for Uterine Cancer, National Cancer Center, Korea, between January 2001 and August 2006. During the study period, 19 patients underwent laparotomic surgical staging and 17 patients underwent laparoscopic surgical staging. No cases were converted from laparoscopy to laparotomy. The two groups were similar in terms of age, body mass index, procedures performed, number of lymph nodes retrieved, and operating time. The laparoscopy group had less estimated blood loss (P = 0.001), faster return of bowel movement (P < 0.001), and a shorter postoperative hospital stay (P = 0.002) compared to the laparotomy group. Transfusions were required only in two laparotomy patients, and postoperative complications occurred only in four laparotomy patients. However, two patients with stage IA grade 1 and 2 disease in laparoscopy group had recurrence with one patient dying of disease. The accuracy and adequacy of laparoscopic surgical staging were comparable to laparotomic approach, and the surgical outcomes were more favorable than laparotomic approach. However, the oncologic safety of laparoscopic staging was not certain. This is the first report on the possible hazards of laparoscopic staging in early-stage ovarian cancer. In the absence of a large prospective trial, this technique should be performed cautiously.

Wednesday, February 23, 2011

Commentary: microRNAs in stage I epithelial ovarian cancer : The Lancet Oncology



"In epithelial ovarian cancer (EOC), miRNA-expression profiles have been described that are associated with different characteristics of ovarian cancer (eg, tumour subtype, stage, histological grade, prognosis, and therapy resistance)........However, these studies should focus on pure histotypes, as EOC is thought to be a heterogeneous disease in which some histotypes are completely different entities all together, with different response outcomes to standard treatment. Another confounding factor for prognostic marker discovery might be exposure to platinum-based combination chemotherapy. Preferably, only patients who did not receive chemotherapy should be analysed for PFS. Because stage I EOC samples are relatively rare, we encourage additional studies to be done by international consortia. With the above-mentioned considerations in mind, valid miRNA biomarkers will be identified that can be of use in the clinic, and help to personalise treatment."